These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 25901861)

  • 1. Targeting Tumor Initiating Cells through Inhibition of Cancer Testis Antigens and Notch Signaling: A Hypothesis.
    Colombo M; Mirandola L; Reidy A; Suvorava N; Konala V; Chiaramonte R; Grizzi F; Rahman RL; Jenkins MR; Nugyen DD; Dalhbeck S; Cobos E; Figueroa JA; Chiriva-Internati M
    Int Rev Immunol; 2015 Mar; 34(2):188-99. PubMed ID: 25901861
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cancer/Testis Antigens: Expression, Regulation, Tumor Invasion, and Use in Immunotherapy of Cancers.
    Salmaninejad A; Zamani MR; Pourvahedi M; Golchehre Z; Hosseini Bereshneh A; Rezaei N
    Immunol Invest; 2016 Oct; 45(7):619-40. PubMed ID: 27603913
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deadly crosstalk: Notch signaling at the intersection of EMT and cancer stem cells.
    Espinoza I; Miele L
    Cancer Lett; 2013 Nov; 341(1):41-5. PubMed ID: 23973264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune response against tumor antigens expressed on human cancer stem-like cells/tumor-initiating cells.
    Hirohashi Y; Torigoe T; Inoda S; Takahashi A; Morita R; Nishizawa S; Tamura Y; Suzuki H; Toyota M; Sato N
    Immunotherapy; 2010 Mar; 2(2):201-11. PubMed ID: 20635928
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Notch signaling pathway and cancer metastasis.
    Hu YY; Zheng MH; Zhang R; Liang YM; Han H
    Adv Exp Med Biol; 2012; 727():186-98. PubMed ID: 22399348
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rational targeting of Notch signaling in cancer.
    Rizzo P; Osipo C; Foreman K; Golde T; Osborne B; Miele L
    Oncogene; 2008 Sep; 27(38):5124-31. PubMed ID: 18758481
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Study of the interaction among Notch pathway receptors, correlation with stemness, as well as their interaction with CD44, dipeptidyl peptidase-IV, hepatocyte growth factor receptor and the SETMAR transferase, in colon cancer stem cells.
    Apostolou P; Toloudi M; Ioannou E; Kourtidou E; Chatziioannou M; Kopic A; Komiotis D; Kiritsis C; Manta S; Papasotiriou I
    J Recept Signal Transduct Res; 2013 Dec; 33(6):353-8. PubMed ID: 23964856
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting notch to eradicate pancreatic cancer stem cells for cancer therapy.
    Wang Z; Ahmad A; Li Y; Azmi AS; Miele L; Sarkar FH
    Anticancer Res; 2011 Apr; 31(4):1105-13. PubMed ID: 21508353
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Notch signaling in cancer stem cells.
    Wang J; Sullenger BA; Rich JN
    Adv Exp Med Biol; 2012; 727():174-85. PubMed ID: 22399347
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cancer stem cells--important players in tumor therapy resistance.
    Colak S; Medema JP
    FEBS J; 2014 Nov; 281(21):4779-91. PubMed ID: 25158828
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Notch Signaling in Macrophages in the Context of Cancer Immunity.
    Palaga T; Wongchana W; Kueanjinda P
    Front Immunol; 2018; 9():652. PubMed ID: 29686671
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cancer-testis antigens: Unique cancer stem cell biomarkers and targets for cancer therapy.
    Gordeeva O
    Semin Cancer Biol; 2018 Dec; 53():75-89. PubMed ID: 30171980
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting Notch signaling for cancer therapeutic intervention.
    Shao H; Huang Q; Liu ZJ
    Adv Pharmacol; 2012; 65():191-234. PubMed ID: 22959027
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cancer stem cells and differentiation therapy.
    Jin X; Jin X; Kim H
    Tumour Biol; 2017 Oct; 39(10):1010428317729933. PubMed ID: 29072131
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Downregulation of Notch Signaling Pathway as an Effective Chemosensitizer for Cancer Treatment.
    Majidinia M; Alizadeh E; Yousefi B; Akbarzadeh M; Zarghami N
    Drug Res (Stuttg); 2016 Nov; 66(11):571-579. PubMed ID: 27701712
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Notch pathway in prostate development and cancer.
    Leong KG; Gao WQ
    Differentiation; 2008 Jul; 76(6):699-716. PubMed ID: 18565101
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gamma-secretase inhibitors target tumor-initiating cells in a mouse model of ERBB2 breast cancer.
    Kondratyev M; Kreso A; Hallett RM; Girgis-Gabardo A; Barcelon ME; Ilieva D; Ware C; Majumder PK; Hassell JA
    Oncogene; 2012 Jan; 31(1):93-103. PubMed ID: 21666715
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monoclonal antibodies against human cancer stem cells.
    Naujokat C
    Immunotherapy; 2014; 6(3):290-308. PubMed ID: 24762074
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cancer stem cells: the promise and the potential.
    Ajani JA; Song S; Hochster HS; Steinberg IB
    Semin Oncol; 2015 Apr; 42 Suppl 1():S3-17. PubMed ID: 25839664
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Notch signaling pathway networks in cancer metastasis: a new target for cancer therapy.
    Li L; Tang P; Li S; Qin X; Yang H; Wu C; Liu Y
    Med Oncol; 2017 Sep; 34(10):180. PubMed ID: 28918490
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.